What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Gene
Steven T. DeKosky mostly deals with Alzheimer's disease, Dementia, Internal medicine, Psychiatry and Gerontology.
His Alzheimer's disease study combines topics in areas such as Apolipoprotein E and Neuroscience.
His Dementia research is multidisciplinary, incorporating perspectives in Depression, Neurology, Cognition and Cohort.
His study focuses on the intersection of Internal medicine and fields such as Endocrinology with connections in the field of Posterior parietal cortex.
He combines subjects such as Placebo, Randomized controlled trial, Epidemiology and Hazard ratio with his study of Gerontology.
The Disease study combines topics in areas such as Biomarker and Intensive care medicine.
His most cited work include:
- Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria (3224 citations)
- The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease (1942 citations)
- Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology (1786 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Dementia, Alzheimer's disease, Internal medicine, Disease and Pathology.
As a member of one scientific family, Steven T. DeKosky mostly works in the field of Dementia, focusing on Gerontology and, on occasion, Cohort.
His work deals with themes such as Central nervous system disease, Neuroscience, Degenerative disease, Psychosis and Apolipoprotein E, which intersect with Alzheimer's disease.
He has included themes like Genetics and Allele in his Apolipoprotein E study.
His Internal medicine study incorporates themes from Endocrinology, Oncology and Cardiology.
As part of one scientific family, Steven T. DeKosky deals mainly with the area of Pathology, narrowing it down to issues related to the Traumatic brain injury, and often Anesthesia.
He most often published in these fields:
- Dementia (31.83%)
- Alzheimer's disease (32.47%)
- Internal medicine (32.47%)
What were the highlights of his more recent work (between 2015-2021)?
- Dementia (31.83%)
- Internal medicine (32.47%)
- Cognition (13.57%)
In recent papers he was focusing on the following fields of study:
Steven T. DeKosky focuses on Dementia, Internal medicine, Cognition, Disease and Cognitive decline.
His Dementia research includes elements of Alzheimer's disease, Epidemiology and Gerontology.
Steven T. DeKosky works on Alzheimer's disease which deals in particular with Pittsburgh compound B.
Internal medicine is closely attributed to Endocrinology in his research.
His studies in Cognition integrate themes in fields like Entorhinal cortex and Audiology.
His work is dedicated to discovering how Disease, Neuroscience are connected with Neurodegeneration and other disciplines.
Between 2015 and 2021, his most popular works were:
- Recommendations for the Nomenclature of Cognitive Change Associated with Anaesthesia and Surgery—2018 (172 citations)
- Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery—2018 (127 citations)
- Transethnic genome-wide scan identifies novel Alzheimer's disease loci (96 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
His primary areas of study are Dementia, Cognition, Cognitive decline, Disease and Internal medicine.
His Dementia study is focused on Pathology in general.
His Cognition research incorporates elements of Anesthesia, Entorhinal cortex and Apolipoprotein E.
His research in Cognitive decline focuses on subjects like Surgery, which are connected to Neuropsychological testing and Cognitive change.
His study in Disease is interdisciplinary in nature, drawing from both Neurology, Neuroscience and Drug.
His research on Pittsburgh compound B concerns the broader Alzheimer's disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
